Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease
The majority of Parkinson’s disease (PD) is sporadic in elderly and is characterized by α-synuclein (αS) aggregation and other alterations involving mitochondria, ubiquitin-proteasome, and autophagy. The remaining are familial PD associated with gene mutations of either autosomal dominant or recessi...
Saved in:
Main Authors: | Jianshe Wei, Gilbert Ho, Yoshiki Takamatsu, Eliezer Masliah, Makoto Hashimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2021/6318067 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Contribution of α-Synuclein Spreading to Parkinson’s Disease Synaptopathy
by: Francesca Longhena, et al.
Published: (2017-01-01) -
Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain
by: Alexandra Dumitriu, et al.
Published: (2012-01-01) -
Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis
by: Simone A. van den Berge, et al.
Published: (2012-01-01) -
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?
by: David Protter, et al.
Published: (2012-01-01) -
Unilateral focal choroidal excavation in autosomal recessive bestrophinopathy
by: Neha Goel
Published: (2025-01-01)